The CYP2A6 polymorphisms showed no significant association with grade 3 or 4 haematological toxicity during the first cycle (leukopenia, P=1.000; neutropenia, P=0.784; anaemia, P=0.353; thrombocytopenia, P=0.169). This evidence concerns the gene CYP2A6 and Thrombocytopenia.